Roads and detours for CAR T cell therapy in autoimmune diseases
J
Jérôme Avouac
A
Adi Barzel
D
Delma Caiati
R
Randall S. Davis
S
Stephen Gottschalk
R
Ricardo Grieshaber-Bouyer
X
Xuming Mao
E
Eline T. Luning Prak
M
Marko Radic
M
Marc Scherlinger
Y
Yatin Suneja
A
Aimee Talleur
A
Amber L. Thacker
D
Derya Unutmaz
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 25, Issue 4
Published
April 01, 2026
Pages
290-309
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (14)
J
Jérôme Avouac
A
Adi Barzel
D
Delma Caiati
R
Randall S. Davis
S
Stephen Gottschalk
R
Ricardo Grieshaber-Bouyer
X
Xuming Mao
E
Eline T. Luning Prak
M
Marko Radic
M
Marc Scherlinger
Y
Yatin Suneja
A
Aimee Talleur
A
Amber L. Thacker
D
Derya Unutmaz
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w